USD 0.0
(N/A%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | - USD | -100.0% |
2021 | 6.5 Million USD | -84.82% |
2020 | 42.87 Million USD | 528.28% |
2019 | 6.82 Million USD | 49.77% |
2018 | 4.55 Million USD | 5.21% |
2017 | 4.33 Million USD | 4.31% |
2016 | 4.15 Million USD | 102.08% |
2015 | 2.05 Million USD | 43.47% |
2014 | 1.43 Million USD | -3.54% |
2013 | 1.48 Million USD | -4.67% |
2012 | 1.55 Million USD | -24.29% |
2011 | 2.05 Million USD | 182.23% |
2010 | 728.76 Thousand USD | 8.56% |
2009 | 671.27 Thousand USD | 334.48% |
2008 | 154.5 Thousand USD | -19.51% |
2007 | 191.95 Thousand USD | 859.76% |
2006 | 20 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 FY | - USD | -100.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | -100.0% |
2022 Q1 | 6.84 Million USD | 5.14% |
2022 Q2 | 6.92 Million USD | 1.25% |
2021 Q1 | 42.99 Million USD | 0.29% |
2021 Q2 | 50.53 Million USD | 17.53% |
2021 FY | 6.5 Million USD | -84.82% |
2021 Q4 | 6.5 Million USD | -87.09% |
2021 Q3 | 50.43 Million USD | -0.2% |
2020 Q1 | 6.65 Million USD | -2.47% |
2020 Q3 | 15.83 Million USD | 128.71% |
2020 Q4 | 42.87 Million USD | 170.77% |
2020 FY | 42.87 Million USD | 528.28% |
2020 Q2 | 6.92 Million USD | 4.03% |
2019 FY | 6.82 Million USD | 49.77% |
2019 Q3 | 6.6 Million USD | 1.44% |
2019 Q2 | 6.51 Million USD | 3.28% |
2019 Q1 | 6.3 Million USD | 38.37% |
2019 Q4 | 6.82 Million USD | 3.31% |
2018 Q2 | 4.34 Million USD | -0.58% |
2018 Q4 | 4.55 Million USD | 0.74% |
2018 FY | 4.55 Million USD | 5.21% |
2018 Q1 | 4.36 Million USD | 0.86% |
2018 Q3 | 4.52 Million USD | 4.15% |
2017 Q2 | 4.22 Million USD | -3.65% |
2017 FY | 4.33 Million USD | 4.31% |
2017 Q4 | 4.33 Million USD | -2.62% |
2017 Q3 | 4.44 Million USD | 5.36% |
2017 Q1 | 4.38 Million USD | 5.53% |
2016 Q3 | 3.85 Million USD | 11.37% |
2016 Q4 | 4.15 Million USD | 7.8% |
2016 FY | 4.15 Million USD | 102.08% |
2016 Q2 | 3.45 Million USD | 27.22% |
2016 Q1 | 2.71 Million USD | 32.3% |
2015 Q1 | 2.29 Million USD | 60.39% |
2015 FY | 2.05 Million USD | 43.47% |
2015 Q4 | 2.05 Million USD | 25.0% |
2015 Q3 | 1.64 Million USD | -24.1% |
2015 Q2 | 2.16 Million USD | -5.71% |
2014 Q2 | 1.07 Million USD | -3.11% |
2014 Q1 | 1.11 Million USD | -25.13% |
2014 FY | 1.43 Million USD | -3.54% |
2014 Q4 | 1.43 Million USD | 21.59% |
2014 Q3 | 1.17 Million USD | 9.35% |
2013 FY | 1.48 Million USD | -4.67% |
2013 Q2 | 1.51 Million USD | -29.46% |
2013 Q4 | 1.48 Million USD | -11.05% |
2013 Q3 | 1.66 Million USD | 10.08% |
2013 Q1 | 2.14 Million USD | 38.01% |
2012 Q4 | 1.55 Million USD | -9.71% |
2012 Q3 | 1.72 Million USD | 5.27% |
2012 Q1 | 1.52 Million USD | -25.92% |
2012 Q2 | 1.63 Million USD | 7.51% |
2012 FY | 1.55 Million USD | -24.29% |
2011 Q2 | 1.81 Million USD | 47.55% |
2011 Q1 | 1.23 Million USD | 69.22% |
2011 Q3 | 1.58 Million USD | -13.02% |
2011 Q4 | 2.05 Million USD | 29.96% |
2011 FY | 2.05 Million USD | 182.23% |
2010 FY | 728.76 Thousand USD | 8.56% |
2010 Q4 | 728.76 Thousand USD | -24.21% |
2010 Q3 | 961.55 Thousand USD | 17.97% |
2010 Q2 | 815.09 Thousand USD | 35.89% |
2010 Q1 | 599.8 Thousand USD | -10.65% |
2009 Q2 | 179.34 Thousand USD | 3.06% |
2009 Q1 | 174.01 Thousand USD | 12.63% |
2009 FY | 671.27 Thousand USD | 334.48% |
2009 Q4 | 671.27 Thousand USD | 238.04% |
2009 Q3 | 198.57 Thousand USD | 10.72% |
2008 Q2 | 159.77 Thousand USD | 2.12% |
2008 FY | 154.5 Thousand USD | -19.51% |
2008 Q3 | 154.5 Thousand USD | -3.3% |
2008 Q4 | 154.5 Thousand USD | 0.0% |
2008 Q1 | 156.45 Thousand USD | -18.49% |
2007 Q2 | 59.91 Thousand USD | 154.4% |
2007 Q4 | 191.95 Thousand USD | 384.24% |
2007 FY | 191.95 Thousand USD | 859.76% |
2007 Q3 | 39.64 Thousand USD | -33.84% |
2007 Q1 | 23.55 Thousand USD | 0.0% |
2006 FY | 20 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ontrak, Inc. | 5.57 Million USD | 100.0% |
Minerva Surgical, Inc. | 51.71 Million USD | 100.0% |